湘北威尔曼制药股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
80
NMPA:80
Drug Approvals
Acetylcysteine Granules
- Product Name
- 乙酰半胱氨酸颗粒
- Approval Number
- 国药准字H20254217
- Approval Date
- May 20, 2025
NMPA
Acetylcysteine Granules
- Product Name
- 乙酰半胱氨酸颗粒
- Approval Number
- 国药准字H20254218
- Approval Date
- May 20, 2025
NMPA
Cefotaxime Sodium and Tazobactam Sodium for Injection
- Product Name
- 注射用头孢噻肟钠他唑巴坦钠
- Approval Number
- 国药准字H20243264
- Approval Date
- Feb 23, 2024
NMPA
Cefotaxime Sodium and Tazobactam Sodium for Injection
- Product Name
- 注射用头孢噻肟钠他唑巴坦钠
- Approval Number
- 国药准字H20243263
- Approval Date
- Feb 23, 2024
NMPA
Cefotaxime Sodium and Sulbactam Sodium for Injection
- Product Name
- 注射用头孢噻肟钠舒巴坦钠
- Approval Number
- 国药准字H20103369
- Approval Date
- Aug 30, 2023
NMPA
Cefotaxime Sodium and Sulbactam Sodium for Injection
- Product Name
- 注射用头孢噻肟钠舒巴坦钠
- Approval Number
- 国药准字H20103368
- Approval Date
- Aug 30, 2023
NMPA
Cefotaxime Sodium and Sulbactam Sodium for Injection
- Product Name
- 注射用头孢噻肟钠舒巴坦钠
- Approval Number
- 国药准字H20090096
- Approval Date
- Aug 30, 2023
NMPA
Cefotaxime Sodium and Sulbactam Sodium for Injection
- Product Name
- 注射用头孢噻肟钠舒巴坦钠
- Approval Number
- 国药准字H20090095
- Approval Date
- Aug 30, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
Clinical Trials
No trials found
News
No news found